Search research articles
Contact Us
Filters
Showing results (11-20 of 181) with videos related to
Page
of 19
Sort By:
The Breast Journal
|
May 16, 2017
Impact of surgery on survival in stage IV breast cancer
Thomas Filleron, Elvire Pons, Amélie Lusque, et al.
Biochemical Pharmacology
|
June 24, 2017
Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death
Julie Leignadier, Florence Dalenc, Marc Poirot, et al.
Breast Cancer Research : BCR
|
May 27, 2021
Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
Victor Sarradin, Amélie Lusque, Thomas Filleron, et al.
Journal of Biomedicine & Biotechnology
|
December 29, 2010
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?
Aurélien Linares, Florence Dalenc, Patrick Balaguer, et al.
Clinical Breast Cancer
|
July 8, 2018
Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report
Victor Sarradin, Florence Dalenc, Vincent Sibaud, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
July 6, 2025
[Information and screening for sexual disorders of patients with non-metastatic breast cancer: Results of a survey]
Auriane Guillier, Florence Dalenc, Sébastien Lamy, et al.
The Breast Journal
|
March 6, 2013
Breast imaging: understanding how accuracy is measured when lesion are the unit of analysis
Thomas Filleron, Florence Dalenc, Frédéric Courbon, et al.
Bulletin Du Cancer
|
January 10, 2021
[Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates]
Florence Dalenc, Victor Sarradin, Vincent Nicolaï, et al.
Computers in Biology and Medicine
|
August 14, 2018
Focus on an infrequently used quantity in the context of competing risks: The conditional probability function
Bastien Cabarrou, Florence Dalenc, Eve Leconte, et al.
Biochimie
|
April 15, 2018
Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite
Marc Poirot, Regis Soules, Arnaud Mallinger, et al.
Page
of 19
Search research articles
Search
Showing results (11-20 of 181) with videos related to
Sort By:
Page
of 19
The Breast Journal
|
May 16, 2017
Impact of surgery on survival in stage IV breast cancer
Thomas Filleron, Elvire Pons, Amélie Lusque, et al.
Biochemical Pharmacology
|
June 24, 2017
Improving the efficacy of hormone therapy in breast cancer: The role of cholesterol metabolism in SERM-mediated autophagy, cell differentiation and death
Julie Leignadier, Florence Dalenc, Marc Poirot, et al.
Breast Cancer Research : BCR
|
May 27, 2021
Immune microenvironment changes induced by neoadjuvant chemotherapy in triple-negative breast cancers: the MIMOSA-1 study
Victor Sarradin, Amélie Lusque, Thomas Filleron, et al.
Journal of Biomedicine & Biotechnology
|
December 29, 2010
Manipulating protein acetylation in breast cancer: a promising approach in combination with hormonal therapies?
Aurélien Linares, Florence Dalenc, Patrick Balaguer, et al.
Clinical Breast Cancer
|
July 8, 2018
Acute Generalized Exanthematous Pustulosis Induced by Docetaxel and Recurrent With Letrozole: A Case Report
Victor Sarradin, Florence Dalenc, Vincent Sibaud, et al.
Gynecologie, Obstetrique, Fertilite & Senologie
|
July 6, 2025
[Information and screening for sexual disorders of patients with non-metastatic breast cancer: Results of a survey]
Auriane Guillier, Florence Dalenc, Sébastien Lamy, et al.
The Breast Journal
|
March 6, 2013
Breast imaging: understanding how accuracy is measured when lesion are the unit of analysis
Thomas Filleron, Florence Dalenc, Frédéric Courbon, et al.
Bulletin Du Cancer
|
January 10, 2021
[Recent therapeutic trends in triple-negative metastatic breast cancers: PARP inhibitors, immunotherapies and antibody-drug conjugates]
Florence Dalenc, Victor Sarradin, Vincent Nicolaï, et al.
Computers in Biology and Medicine
|
August 14, 2018
Focus on an infrequently used quantity in the context of competing risks: The conditional probability function
Bastien Cabarrou, Florence Dalenc, Eve Leconte, et al.
Biochimie
|
April 15, 2018
Chemistry, biochemistry, metabolic fate and mechanism of action of 6-oxo-cholestan-3β,5α-diol (OCDO), a tumor promoter and cholesterol metabolite
Marc Poirot, Regis Soules, Arnaud Mallinger, et al.
Page
of 19